All
Terbinafine shows dose-dependency in tinea capitis
June 1st 2002New Orleans - Dose rather than duration of therapy appears to be the important factor for achieving favorable cure rates using oral terbinafine (Lamisil) for the treatment of tinea capitis, Sheila Fallon Friedlander, M.D., said at the annual meeting of the American Academy of Dermatology.
EMLA, ELA-MAX, topicaine remain anesthetic standards
May 1st 2002New Orleans - Selecting an appropriate topical anesthetic agent requires a knowledge of the biochemistry and mechanisms of action of these agents to ensure efficacy and a quick onset of action, Christopher J. Arpey, M.D., said at the annual meeting of the American Academy of Dermatology.
Helpful hints for hard-to-heal wounds
May 1st 2002New Orleans - Chronic wound healing can be enhanced through a variety of products that encompass systemic agents such as pentoxifylline and aspirin to tissue-engineered skin and growth factors that stimulate healing, according to Robert S. Kirsner, MD.
Skin cancer Tx poses challenges to transplant patients
May 1st 2002New Orleans - Management of skin cancer in organ transplant recipientspresents numerous challenges, but there are also many opportunities fornew approaches that will improve the care of these patients, Clark C. Otley,M.D., said at the annual meeting of the American Academy of Dermatology.
Sorting through immunomodulatory psoriasis agents
May 1st 2002Norman Levine, M.D., professor and chief of dermatology, University of Arizona, and Gerald G. Krueger, M.D., professor of dermatology, Cumming Presidential Endowed Chair, University of Utah, discuss immunomodulatory agents in the treatment of psoriasis.
Greater UVA protection equates to improved immune protection
May 1st 2002New Orleans - The level of UVA protection afforded by a broad-spectrum sunscreen determines its ability to protect against UV-induced immune suppression, according to a study presented by Dominique Moyal, Ph.D., at the annual meeting of the American Academy of Dermatology.
One percent PTZ shampoo increases hair density
May 1st 2002New Orleans - Regular use of a commercially available antidandruff shampoo containing 1 percent pyrithione zinc (PTZ) does not adversely affect hair loss in men with androgenetic alopecia and may in fact slow its progression or result in improvement, according to the results of a prospective, randomized, controlled investigation.
Intralesional plus steroid offers eyebrow regrowth
May 1st 2002New Orleans - Combined intralesional and topical corticosteroid treatment can be effective for reversing eyebrow hair loss in patients with alopecia totalis and alopecia universalis, Jordana S. Gilman, M.D., reported at the annual meeting of the American Academy of Dermatology.
Ambulatory phlebectomy easily handled
April 1st 2002New Orleans - Ambulatory phlebectomy is a safe and effective outpatient procedure for treating varicose and reticular veins that offers a host of advantages compared with alternative techniques, Mitchel P. Goldman, M.D., said at the annual meeting of the American Academy of Dermatology.
The right stuff: a primer in closing of wounds
April 1st 2002New Orleans - Suture materials and needle choices for clinicians can seem to be limitless, according to Margaret Terhune, M.D. Dr. Terhune presented a thorough review of the materials and methods surgeons can select for wound closure here at the annual meeting of the American Academy of Dermatology.
Lesion size, location dictate decision on pediatric surgery
April 1st 2002New Orleans - Timing is key for a successful outcome when performing dermatologic surgery in pediatric patients, and lesion size and location are the two most important variables factoring into the equation, Annette M. Wagner, M.D., said at the annual meeting of the American Academy of Dermatology.
Systemic CD often an elusive diagnosis
April 1st 2002New Orleans - Systemic contact dermatitis may present with a variety of eczematous and noneczematous cutaneous reaction patterns and may be an overlooked diagnosis unless clinicians maintain an index of suspicion that systemic exposure to a contact allergen is driving the skin eruption, Donald V. Belsito, M.D., said at the annual meeting of the American Academy of Dermatology.
Skin manifestations signal hepatitis C virus infection
April 1st 2002New Orleans - Dermatologists need to be aware that hepatitis C virus (HCV) infection may present with cutaneous manifestations because early diagnosis and treatment are critical for reducing morbidity and mortality from progression of the underlying infectious disease, Julia R. Nunley, M.D., said at the annual meeting of the American Academy of Dermatology.